{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:19:21Z","timestamp":1779333561791,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44-DE025524"],"award-info":[{"award-number":["R44-DE025524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R42-DE025789"],"award-info":[{"award-number":["R42-DE025789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R37-AA018282"],"award-info":[{"award-number":["R37-AA018282"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R21-DE028076"],"award-info":[{"award-number":["R21-DE028076"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R44-AI125060-02"],"award-info":[{"award-number":["R44-AI125060-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bone.2020.115711","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:55:48Z","timestamp":1603536948000},"page":"115711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Bisphosphonates in veterinary medicine: The new horizon for use"],"prefix":"10.1016","volume":"142","author":[{"given":"Larry J.","family":"Suva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlee E.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank H.","family":"Ebetino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Gaddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bone.2020.115711_bb0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archinte.1969.00300210053007","article-title":"Pyrophosphate and diphosphonates in calcium metabolism and their possible role in renal failure","volume":"124","author":"Russell","year":"1969","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.bone.2020.115711_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115711_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jlac.18651330307","article-title":"Ueber die Einwirkung des Chloracetyls auf phosphorige Saure","volume":"133","author":"Menschutkin","year":"1865","journal-title":"Ann Chem Pharmacol"},{"issue":"5065","key":"10.1016\/j.bone.2020.115711_bb0020","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.bone.2020.115711_bb0025","doi-asserted-by":"crossref","first-page":"115493","DOI":"10.1016\/j.bone.2020.115493","article-title":"Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton","volume":"139","author":"Rogers","year":"2020","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2020.115711_bb0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115711_bb0035","series-title":"Principles of Bone Biology","first-page":"1737","article-title":"Bisphoshonates. Mechanism of action","author":"Roelofs","year":"2008"},{"issue":"20","key":"10.1016\/j.bone.2020.115711_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/vr.102104","article-title":"Quantitative evaluation of bone scintigraphy of the spinous processes of the equine thoracic spine at different times after administering (9)(9)mTc-hydroxymethylene-diphosphonate","volume":"174","author":"Sporn","year":"2014","journal-title":"Vet Rec"},{"issue":"12","key":"10.1016\/j.bone.2020.115711_bb0045","article-title":"Navicular syndrome in equine patients anatomy, causes, and diagnosis","volume":"32","author":"Waguespack","year":"2010","journal-title":"Compend Contin Educ Vet"},{"issue":"1","key":"10.1016\/j.bone.2020.115711_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00223-017-0261-8","article-title":"Long-term bone scintigraphy results after intravenous zoledronate in Paget\u2019s disease of bone","volume":"101","author":"Reid","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"6","key":"10.1016\/j.bone.2020.115711_bb0055","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms","volume":"60","author":"Sedghizadeh","year":"2017","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030154","article-title":"Synthesis of a bone-targeted bortezomib with in vivo anti-myeloma effects in mice","volume":"10","author":"Wang","year":"2018","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.bone.2020.115711_bb0065","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jnci\/djk054","article-title":"Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis","volume":"99","author":"Daubine","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"21","key":"10.1016\/j.bone.2020.115711_bb0070","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1158\/0008-5472.CAN-08-2195","article-title":"Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo","volume":"68","author":"Fournier","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2020.115711_bb0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12885-015-1066-7","article-title":"The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway","volume":"15","author":"Wilson","year":"2015","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.bone.2020.115711_bb0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"Varela","year":"2008","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0085","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/stem.2255","article-title":"Zoledronate attenuates accumulation of DNA damage in mesenchymal stem cells and protects their function","volume":"34","author":"Misra","year":"2016","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0090","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/evj.13011","article-title":"Clodronate improves lameness in horses without changing bone turnover markers","volume":"51","author":"Mitchell","year":"2019","journal-title":"Equine Vet. J."},{"issue":"4","key":"10.1016\/j.bone.2020.115711_bb0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/evj.12265","article-title":"Pain control in horses: what do we really know?","volume":"46","author":"Sanchez","year":"2014","journal-title":"Equine Vet. J."},{"issue":"2","key":"10.1016\/j.bone.2020.115711_bb0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1939-1676.2008.0046.x","article-title":"The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis","volume":"22","author":"Fan","year":"2008","journal-title":"J. Vet. Intern. Med."},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1532-950X.2012.00968.x","article-title":"The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy","volume":"41","author":"Oblak","year":"2012","journal-title":"Vet. Surg."},{"issue":"5","key":"10.1016\/j.bone.2020.115711_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/vr.147.5.129","article-title":"Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs","volume":"147","author":"Tomlin","year":"2000","journal-title":"Vet Rec"},{"issue":"10","key":"10.1016\/j.bone.2020.115711_bb0115","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2020.115711_bb0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14310\/horm.2002.1226","article-title":"Bisphosphonate-associated adverse events","volume":"8","author":"Papapetrou","year":"2009","journal-title":"Hormones (Athens)"},{"issue":"11","key":"10.1016\/j.bone.2020.115711_bb0125","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.bone.2020.115711_bb0130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1470-2045(14)70302-X","article-title":"Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01\/04) randomised open-label phase 3 trial","volume":"15","author":"Coleman","year":"2014","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.bone.2020.115711_bb0135","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2020.115711_bb0140","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jvim.15409","article-title":"Medication-related osteonecrosis of the jaw after long-term bisphosphonate treatment in a cat","volume":"33","author":"Larson","year":"2019","journal-title":"J. Vet. Intern. Med."},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1601-6343.2009.01456.x","article-title":"Mandibular necrosis in beagle dogs treated with bisphosphonates","volume":"12","author":"Burr","year":"2009","journal-title":"Orthod Craniofac Res"},{"issue":"5","key":"10.1016\/j.bone.2020.115711_bb0150","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/JPER.19-0213","article-title":"Aminobisphosphonate-treated ewes as a model of osteonecrosis of the jaw and of dental implant failure","volume":"91","author":"Davison","year":"2020","journal-title":"J. Periodontol."},{"issue":"4","key":"10.1016\/j.bone.2020.115711_bb0155","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/jvim.13980","article-title":"Zoledronate-associated osteonecrosis of the jaw in a dog with appendicular osteosarcoma","volume":"30","author":"Lundberg","year":"2016","journal-title":"J. Vet. Intern. Med."},{"issue":"2","key":"10.1016\/j.bone.2020.115711_bb0160","article-title":"Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat","volume":"3","author":"N. Council","year":"2017","journal-title":"JFMS Open Rep"},{"key":"10.1016\/j.bone.2020.115711_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2019.03.027","article-title":"Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice","volume":"123","author":"Hokugo","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115711_bb0170","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3201\/eid1409.086672","volume":"14","author":"Schultz","year":"2008","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.bone.2020.115711_bb0175","author":"H.o.O. Health"},{"issue":"4","key":"10.1016\/j.bone.2020.115711_bb0180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10585-011-9377-9","article-title":"Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice","volume":"28","author":"Wolfe","year":"2011","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.bone.2020.115711_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrendo.2015.185","article-title":"The best of both worlds - managing the cancer, saving the bone","volume":"12","author":"Makhoul","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0190","first-page":"431","article-title":"Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain","volume":"21","author":"Fan","year":"2007","journal-title":"J. Vet. Intern. Med."},{"issue":"4","key":"10.1016\/j.bone.2020.115711_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1476-5810.2003.00026.x","article-title":"The bisphosphonates alendronate and zoledronate are inhibitors of canine and human osteosarcoma cell growth in vitro","volume":"1","author":"Poirier","year":"2003","journal-title":"Vet. Comp. Oncol."},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/vco.12040","article-title":"Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma","volume":"13","author":"Kozicki","year":"2015","journal-title":"Vet. Comp. Oncol."},{"issue":"2","key":"10.1016\/j.bone.2020.115711_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cvsm.2016.09.004","article-title":"Update on feline ionized hypercalcemia","volume":"47","author":"de Brito Galvao","year":"2017","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"2","key":"10.1016\/j.bone.2020.115711_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jfms.2010.09.011","article-title":"Use of bisphosphonates to treat severe idiopathic hypercalcaemia in a young Ragdoll cat","volume":"13","author":"Whitney","year":"2011","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.bone.2020.115711_bb0215","first-page":"171","article-title":"Current perspectives on the optimal age to spay\/castrate dogs and cats","volume":"6","author":"Howe","year":"2015","journal-title":"Vet Med (Auckl)"},{"key":"10.1016\/j.bone.2020.115711_bb0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anireprosci.2015.09.001","article-title":"Osteoporotic risk and physeal closure in prepubertal ovariohysterectomized cats","volume":"161","author":"Ucmak","year":"2015","journal-title":"Anim. Reprod. Sci."},{"issue":"7","key":"10.1016\/j.bone.2020.115711_bb0225","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jfms.2011.05.007","article-title":"Young, male neutered, obese, lame? Non-traumatic fractures of the femoral head and neck","volume":"13","author":"Lafuente","year":"2011","journal-title":"J Feline Med Surg"},{"issue":"6","key":"10.1016\/j.bone.2020.115711_bb0230","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jat.2935","article-title":"Drug safety testing paradigm, current progress and future challenges: an overview","volume":"34","author":"Ahuja","year":"2014","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.bone.2020.115711_bb0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0749-0739(17)30606-5","article-title":"Pathophysiology of navicular syndrome","volume":"5","author":"Pool","year":"1989","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"11","key":"10.1016\/j.bone.2020.115711_bb0240","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2460\/javma.240.11.1323","article-title":"Use of zoledronate for treatment of a bone fragility disorder in horses","volume":"240","author":"Katzman","year":"2012","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"5","key":"10.1016\/j.bone.2020.115711_bb0245","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/evj.13244","article-title":"Pharmacokinetics and pharmacodynamics of clodronate disodium evaluated in plasma, synovial fluid and urine","volume":"52","author":"Krueger","year":"2020","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.bone.2020.115711_bb0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12917-018-1423-2","article-title":"Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial","volume":"14","author":"Richbourg","year":"2018","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.bone.2020.115711_bb0255","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.2042-3306.2010.00221.x","article-title":"Heel effects on joint contact force components in the equine digit: a sensitivity analysis","volume":"38","author":"Noble","year":"2010","journal-title":"Equine Vet J Suppl"},{"issue":"9041","key":"10.1016\/j.bone.2020.115711_bb0260","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.bone.2020.115711_bb0265","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bone.2020.115711_bb0270","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.2042-3306.1999.tb03805.x","article-title":"Three dimensional structure of the distal condyles of the third metacarpal bone of the horse","volume":"31","author":"Boyde","year":"1999","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.bone.2020.115711_bb0275","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jevs.2008.02.007","article-title":"A review of the efficacy of tiludronate in the horse","volume":"28","author":"Kamm","year":"2008","journal-title":"J. Equine. Vet. Sci."},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/8756-3282(95)00221-X","article-title":"The response of the skeleton to physical training: a biochemical study in horses","volume":"17","author":"Price","year":"1995","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2020.115711_bb0285","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2746\/042516409X416206","article-title":"Bone biomarkers and risk of fracture in two- and three-year-old thoroughbreds","volume":"41","author":"Jackson","year":"2009","journal-title":"Equine Vet. J."},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0290","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bone.2007.05.005","article-title":"Pharmacological effects of tiludronate in horses after long-term immobilization","volume":"41","author":"Delguste","year":"2007","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2020.115711_bb0295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12917-019-1966-x","article-title":"Bisphosphonate use in the horse: what is good and what is not?","volume":"15","author":"Mitchell","year":"2019","journal-title":"BMC Vet. Res."},{"issue":"10","key":"10.1016\/j.bone.2020.115711_bb0300","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s10067-017-3681-y","article-title":"Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation)","volume":"36","author":"Saviola","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.bone.2020.115711_bb0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2460\/ajvr.68.3.329","article-title":"Efficacy of tiludronate in the treatment of horses with signs of pain associated with osteoarthritic lesions of the thoracolumbar vertebral column","volume":"68","author":"Coudry","year":"2007","journal-title":"Am. J. Vet. Res."},{"issue":"5","key":"10.1016\/j.bone.2020.115711_bb0310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.2042-3306.2010.00120.x","article-title":"Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial","volume":"42","author":"Gough","year":"2010","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.bone.2020.115711_bb0315","article-title":"Pharmacology of bisphosphonates in pain","author":"Tzschentke","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bone.2020.115711_bb0320","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00003072-200011000-00009","article-title":"Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy","volume":"25","author":"Liepe","year":"2000","journal-title":"Clin. Nucl. Med."},{"issue":"31","key":"10.1016\/j.bone.2020.115711_bb0325","doi-asserted-by":"crossref","first-page":"E6297","DOI":"10.1073\/pnas.1704847114","article-title":"Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain","volume":"114","author":"Kato","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.bone.2020.115711_bb0330","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1097\/MIB.0000000000000920","article-title":"The bisphosphonate pamidronate is an intestinal antiinflammatory agent in rat and mouse experimental colitis","volume":"22","author":"Lopez-Posadas","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"24","key":"10.1016\/j.bone.2020.115711_bb0335","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2018.19319","article-title":"Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis","volume":"320","author":"Gregori","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.bone.2020.115711_bb0340","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/AJP.0000000000000739","article-title":"Individualization of migraine prevention: a randomized controlled trial of psychophysical-based prediction of duloxetine efficacy","volume":"35","author":"Kisler","year":"2019","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.bone.2020.115711_bb0345","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tvjl.2019.02.001","article-title":"Pain assessment in horses after orthopaedic surgery and with orthopaedic trauma","volume":"246","author":"van Loon","year":"2019","journal-title":"Vet. J."},{"key":"10.1016\/j.bone.2020.115711_bb0350","doi-asserted-by":"crossref","first-page":"102874","DOI":"10.1016\/j.jevs.2019.102874","article-title":"What do we know about clodronate now? A medical and veterinary perspective","volume":"88","author":"Markell","year":"2020","journal-title":"J Equine Vet Sci"},{"issue":"10","key":"10.1016\/j.bone.2020.115711_bb0355","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/dta.2892","article-title":"An innovative derivatization-free IC-MS\/MS method for the detection of bisphosphonates in horse plasma","volume":"12","author":"Garcia","year":"2020","journal-title":"Drug Test Anal"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:51:27Z","timestamp":1757613087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220304919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":71,"alternative-id":["S8756328220304919"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115711","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates in veterinary medicine: The new horizon for use","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115711"}}